AstraZeneca / Prilosec
(https://prilosec.com) 📸 Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
There is a severe authority gap where the schema_json claims the entity is Multibrand at azpicentral.com, failing to match the Prilosec domain name. No experts, medical professionals, or researchers are named, leaving the brand without a verifiable digital footprint or technical authority. The technical credibility is further undermined by a broken heading hierarchy, which features an H2 tag without a preceding H1 tag to establish the page’s primary topic.
The site fails to demonstrate even basic technical or professional competence, which is a major disconnect for a brand associated with AstraZeneca Medicines. There are zero performance claims regarding efficacy, safety, or patient outcomes because the page content has vanished into a 404 state. The marketing tone is entirely replaced by technical error text, providing the ultimate proof of a performance gap between brand expectation and digital reality.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "http://schema.org",
"@type": "WebSite",
"name": "Multibrand",
"url": "https://www.azpicentral.com"
}
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
This page presents a snapshot of public data from AstraZeneca / Prilosec, captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to AstraZeneca / Prilosec: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://prilosec.com to view the most current version of its content and see directly what this company is about and what it offers.